TrialPloS one2014

Retrospective analysis of survival improvement by molecular biomarker-based personalized chemotherapy for recurrent ovarian cancer.

Youngchul Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.